| 2051 |
Hybridization |
Live |
28/04/2022 |
| 2047 |
LPA Processes |
Live |
28/04/2022 |
| 2052 |
Contamination control |
Pending Review |
28/04/2022 |
| 2045 |
LPA Reporting, Interpretation of results and evaluation of LPA Assay strips |
Live |
27/04/2022 |
| 2046 |
LPA Quality Assurance |
Live |
27/04/2022 |
| 2044 |
LPA Biosafety |
Live |
27/04/2022 |
| 813 |
99 DOTS- Troubleshooting |
Live |
27/04/2022 |
| 811 |
99 DOTS- Self Reporting Adherence |
Live |
27/04/2022 |
| 810 |
99 DOTS- Initiating adherence monitoring of the patient |
Live |
27/04/2022 |
| 809 |
99 DOTS- Envelope Dispensing Process |
Live |
27/04/2022 |
| 480 |
Second Line LPA [SLLPA] |
Live |
27/04/2022 |
| 479 |
First Line LPA [FLLPA] |
Live |
27/04/2022 |
| 2048 |
LPA Troubleshooting |
Live |
27/04/2022 |
| 221 |
Respiratory Hygiene |
Live |
27/04/2022 |
| 226 |
Administrative measures for AIC at a Health Facility |
Live |
27/04/2022 |
| 223 |
IPC practices required at a DMC |
Live |
27/04/2022 |
| 203 |
Random Blinded ReChecking [RBRC] Concept |
Live |
27/04/2022 |
| 148 |
Role of Medical Officer at and around a DMC in TB Diagnosis |
Live |
27/04/2022 |
| 486 |
Culture Drug Susceptibility Testing [CDST] |
Live |
27/04/2022 |
| 284 |
Need to communicate results to patient |
Live |
26/04/2022 |
| 197 |
Need for Quality Testing and Control |
Live |
26/04/2022 |
| 151 |
Role of STS at a DMC |
Live |
26/04/2022 |
| 150 |
Role of STLS at a DMC |
Live |
26/04/2022 |
| 149 |
Role of Peripheral Health Care workers around a DMC in TB Care |
Live |
26/04/2022 |
| 1252 |
LPA: Principles and Technique |
Live |
26/04/2022 |
| 483 |
LPA for DR-TB Diagnosis |
Live |
26/04/2022 |
| 227 |
Use of a PPE in a DMC |
Live |
25/04/2022 |
| 1343 |
Ayushman Bharat Health and Wellness Centres |
Live |
25/04/2022 |
| 280 |
Counselling for TB treatment initiation |
Live |
22/04/2022 |
| 241 |
TB Treatment Initiation |
Live |
22/04/2022 |
